Balyasny Asset Management
IFRX icon

Balyasny Asset Management’s InflaRx IFRX Stock Holding History

Balyasny Asset Management’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,534
Closed -$19.3K – 2817
2024
Q1 		$19.3K Buy
+12,534
New +$20.5K ﹤0.01% 2539

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Balyasny Asset Management's IFRX Position: Q2 2024 in Review

Balyasny Asset Management sold out of InflaRx (IFRX) in Q2 2024, closing a stake of 12,534 shares — an estimated $19.3K sold.

Balyasny Asset Management first reported a position in IFRX in Q1 2024 and held it in 1 quarter. The position peaked at $19.3K in Q1 2024. 33 funds tracked by Wall St. Rank hold IFRX as of Q2 2024.

  • Balyasny Asset Management reported no remaining InflaRx position as of Q2 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 12,534 InflaRx shares in Q2 2024, an estimated $19.3K.
  • Balyasny Asset Management first reported a position in InflaRx in Q1 2024 and held it in 1 quarter.
  • Balyasny Asset Management's InflaRx position peaked at $19.3K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held InflaRx as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.